Therapeutic efficacy of humanized anti-IL-6-receptor antibody in systemic juvenile idiopathic arthritis.

被引：0
|
作者：
Yokota, S
Miyamae, T
Imagawa, T
Nishimoto, N
Yoshizaki, K
Hirsch, R
Mori, M
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1432
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [1] Long-term therapeutic efficacy of humanized anti-il 6-receptor antibody for systemic juvenile idiopathic arthritis.
    Yokota, S
    Miyamae, TK
    Imagawa, T
    Nishimoto, N
    Yoshizaki, K
    Mori, M
    Hirsch, R
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S479 - S479
  • [2] Anti-IL-6 receptor antibody therapy of a girl with severe systemic juvenile idiopathic arthritis.
    Yamazaki, T
    Agematsu, K
    Tanaka, M
    Nagumo, H
    Yasui, K
    Komiyama, A
    [J]. CLINICAL IMMUNOLOGY, 2002, 103 (03) : S81 - S81
  • [3] Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Imagawa, Tomoyuki
    Yokota, Shumpei
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (01) : 109 - 115
  • [4] Therapeutic Efficacy of Humanized Recombinant Anti-Interleukin-6 Receptor Antibody in Children With Systemic-Onset Juvenile Idiopathic Arthritis
    Yokota, Shumpei
    Miyamae, Takako
    Imagawa, Tomoyuki
    Iwata, Naomi
    Katakura, Shigeki
    Mori, Masaaki
    Woo, Patricia
    Nishimoto, Norihiro
    Yoshizaki, Kazuyuki
    Kishimoto, Tadamitsu
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 818 - 825
  • [5] Efficacy and safety of tocilizumab, an anti-IL-6 receptor monoclonal antibody; in patients with polyarticular or oligoarticular onset juvenile idiopathic arthritis.
    Imagawa, Tomoyuki
    Mori, Masaaki
    Takei, Syuji
    Kawano, Yoshifumi
    Iwata, Naomi
    Miyoshi, Mari
    Murata, Takuji
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    Yokota, Shumpei
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S168 - S168
  • [6] Radiological Evaluation of Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab, An Anti-IL6 Receptor Monoclonal Antibody.
    Aoki, Chie
    Inaba, Yutaka
    Imagawa, Tomoyuki
    Miyamae, Takako
    Mori, Masaaki
    Saito, Tomoyuki
    Yokota, Shumpei
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1031 - S1032
  • [7] Long-term therapeutic experience of humanized anti-IL-6 receptor monoclonal antibody (aIL-6R Mab) in systemic-onset juvenile idiopathic arthritis (So-JIA).
    Yokota, S
    Imagawa, T
    Miyamae, T
    Mori, M
    Nishimoto, N
    Kishimoto, T
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S438 - S438
  • [8] Long-term treatment of systemic onset juvenile idiopathic arthritis (SO-JIA) with humanized anti-IL-6 receptor monoclonal antibody, tocilizumab (Actemra®)
    Yokota, S
    Miyamae, T
    Kurosawa, R
    Ozawa, R
    Imagawa, T
    Mori, M
    Nishimoto, N
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S725 - S725
  • [9] Phase II trial of anti-IL-6 receptor antibody (MRA) for children with systemic-onset juvenile idiopathic arthritis
    Yokota, S
    Miyamae, T
    Imagawa, T
    Iwata, N
    Katakura, S
    Mori, M
    Nishimoto, N
    Yoshizaki, K
    Woo, P
    Hirsch, R
    Kishimoto, T
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S429 - S429
  • [10] Catch-up growth in severe systemic-onset juvenile idiopathic arthritis: Long-term treatment with humanized anti-IL6 receptor monoclonal antibody
    Imagawa, T
    Miyamae, T
    Umebayashi, H
    Kurosawa, R
    Katakura, S
    Mori, M
    Nishimoto, N
    Yokota, S
    Kishimoto, T
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S91 - S92
12345